Magnetic resonance imaging in the management of prolactinomas; a review of the evidence

Pituitary. 2020 Feb;23(1):16-26. doi: 10.1007/s11102-019-01001-6.

Abstract

Purpose: This review aimed to evaluate data on the use of magnetic resonance imaging in the management of prolactinomas.

Methods: Recent literature about prolactinoma behavior and magnetic resonance imaging in the management of prolactinomas is reviewed.

Results: A review of evidence regarding prolactinoma pituitary MRI follow-up; techniques and sequences, recent data on possible gadolinium retention, the role and a review of T2-weighted images in the identification of prolactinomas and frequently encountered clinical scenarios, as well as MRI correlation with prolactin secretion, tumor growth and prediction of response to medical therapy are presented.

Conclusion: The underlying decision to perform serial imaging in prolactinoma patients should be individualized on a case-by-case basis. Future studies should focus on alternative imaging methods and/or contract agents.

Keywords: Gadolinium; Lactotroph adenoma; Magnetic resonance imaging; Prolactinoma; T2-weighted.

Publication types

  • Review

MeSH terms

  • Humans
  • Magnetic Resonance Imaging / methods*
  • Pituitary Neoplasms / blood
  • Pituitary Neoplasms / diagnostic imaging*
  • Prolactin / blood
  • Prolactinoma / blood
  • Prolactinoma / diagnostic imaging*

Substances

  • Prolactin